Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


4 Ann Intern Med
3 Cell
2 Epidemiol Infect
10 J Infect Dis
1 J Virol
2 Lancet
2 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
1 PLoS Biol
1 PLoS Genet
10 PLoS One
3 Proc Natl Acad Sci U S A
3 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

    Ann Intern Med. 2021 Nov 9. doi: 10.7326/AITC202111160.
    PubMed         Abstract available

    Ann Intern Med. 2021;174:1474-1475.

  3. DELANEY SW, Essien UR, Navathe A
    Disparate Impact: How Colorblind Policies Exacerbate Black-White Health Inequities.
    Ann Intern Med. 2021;174:1450-1451.

  4. SANGLI S, Virani A, Cheronis N, Vannatter B, et al
    Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine.
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/L21-0244.


  5. COSTELLO A, Clark H, Kobia M, Martinez J, et al
    Adolescents have not been well served by responses to the pandemic and the climate crisis.
    BMJ. 2021;375:n2649.

  6. EZER N, Belga S, Daneman N, Chan A, et al
    Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial.
    BMJ. 2021;375:e068060.
    PubMed         Abstract available

    Covid vaccine committee decisions: don't forget JCVI has little or no extra resources to do many times its usual work.
    BMJ. 2021;375:n2646.

  8. SOKOL D
    Covid-19 vaccination should be mandatory for healthcare workers.
    BMJ. 2021;375:n2670.

  9. ISLAM N, Jdanov DA, Shkolnikov VM, Khunti K, et al
    Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries.
    BMJ. 2021;375:e066768.
    PubMed         Abstract available

  10. REICHER S, Drury J, Phoenix A, Stokoe L, et al
    Government ministers and MPs not wearing mask was bad enough, but their defence of this position is even worse.
    BMJ. 2021;375:n2682.

  11. SLEAT D, Innes K, Parker I
    Are vaccine passports and covid passes a valid alternative to lockdown?
    BMJ. 2021;375:n2571.


  12. SHAPIRO L, Losick R
    Delivering the message: How a novel technology enabled the rapid development of effective vaccines.
    Cell. 2021;184:5271-5274.
    PubMed         Abstract available

  13. Persistent progress.
    Cell. 2021;184:5293-5296.
    PubMed         Abstract available

  14. CROSS G, Ho JSY, Zacharias W, Jeyasekharan AD, et al
    Emergency drug use in a pandemic: Harsh lessons from COVID-19.
    Cell. 2021;184:5497-5500.
    PubMed         Abstract available

    Epidemiol Infect

  15. JUUTINEN A, Sarvikivi E, Laukkanen-Nevala P, Helve O, et al
    Closing lower secondary schools had no impact on COVID-19 incidence in 13-15-year-olds in Finland.
    Epidemiol Infect. 2021;149:e233.
    PubMed         Abstract available

  16. MANCILLA-GALINDO J, Kammar-Garcia A, Martinez-Esteban A, Meza-Comparan HD, et al
    COVID-19 patients with increasing age experience differential time to initial medical care and severity of symptoms.
    Epidemiol Infect. 2021;149:e230.
    PubMed         Abstract available

    J Infect Dis

  17. DIMCHEFF DE, Valesano AL, Rumfelt KE, Fitzsimmons WJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Total and Subgenomic RNA Viral Load in Hospitalized Patients.
    J Infect Dis. 2021;224:1287-1293.
    PubMed         Abstract available

  18. DE GIORGI V, West KA, Henning AN, Chen LN, et al
    Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.
    J Infect Dis. 2021;224:1294-1304.
    PubMed         Abstract available

  19. SHRWANI K, Sharma R, Krishnan M, Jones T, et al
    Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    J Infect Dis. 2021;224:1305-1315.
    PubMed         Abstract available

  20. GANESH R, Philpot LM, Bierle DM, Anderson RJ, et al
    Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
    J Infect Dis. 2021;224:1278-1286.
    PubMed         Abstract available

  21. LI K, Wohlford-Lenane C, Bartlett JA, McCray PB, et al
    Intersubject Variation in ACE2 Protein Expression in Human Airway Epithelia and Its Relationship to Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2021;224:1357-1361.
    PubMed         Abstract available

  22. BJORKMAN KK, Saldi TK, Lasda E, Bauer LC, et al
    Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.
    J Infect Dis. 2021;224:1316-1324.
    PubMed         Abstract available

  23. SANTOS BRAVO M, Nicolas D, Berengua C, Fernandez M, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Normalized Viral Loads and Subgenomic RNA Detection as Tools for Improving Clinical Decision Making and Work Reincorporation.
    J Infect Dis. 2021;224:1325-1332.
    PubMed         Abstract available

  24. YANG Y, Kuang L, Li L, Wu Y, et al
    Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019.
    J Infect Dis. 2021;224:1333-1344.
    PubMed         Abstract available

  25. HORTON DB, Barrett ES, Roy J, Gennaro ML, et al
    Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
    J Infect Dis. 2021;224:1345-1356.
    PubMed         Abstract available

  26. OWUSU D, Pomeroy MA, Lewis NM, Wadhwa A, et al
    Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
    J Infect Dis. 2021;224:1362-1371.
    PubMed         Abstract available

    J Virol

  27. SOUZA CK, Anderson TK, Chang J, Venkatesh D, et al
    Antigenic distance between North American swine and human seasonal H3N2 influenza A viruses as an indication of zoonotic risk to humans.
    J Virol. 2021 Nov 10:JVI0137421. doi: 10.1128/JVI.01374.
    PubMed         Abstract available


  28. GARDNER C, Kleinman A
    Medicine and the unconscious.
    Lancet. 2021;398:112-113.

  29. LEHTIMAKI S, Allotey P, Schwalbe N
    Pandemic response requires early and robust verification.
    Lancet. 2021;398:115.

    MMWR Morb Mortal Wkly Rep

  30. QuickStats: Percentage* of Adults Aged >/=18 Years Who Received an Influenza Vaccination in the Past 12 Months,(dagger) by Sex and Age Group - National Health Interview Survey,( section sign) United States, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1586.

  31. ROMAN PC, Kirtland K, Zell ER, Jones-Jack N, et al
    Influenza Vaccinations During the COVID-19 Pandemic - 11 U.S. Jurisdictions, September-December 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1575-1578.
    PubMed         Abstract available

    N Engl J Med

  32. PAVORD S, Scully M, Hunt BJ, Lester W, et al
    Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    N Engl J Med. 2021 Aug 11. doi: 10.1056/NEJMoa2109908.
    PubMed         Abstract available

  33. SHAH ASV, Gribben C, Bishop J, Hanlon P, et al
    Effect of Vaccination on Transmission of SARS-CoV-2.
    N Engl J Med. 2021 Sep 8. doi: 10.1056/NEJMc2106757.

  34. CHIN MH
    Uncomfortable Truths - What Covid-19 Has Revealed about Chronic-Disease Care in America.
    N Engl J Med. 2021;385:1633-1636.

  35. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children.
    N Engl J Med. 2021;385:e74.

    PLoS Biol

  36. JACK A, Ferro LS, Trnka MJ, Wehri E, et al
    SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA.
    PLoS Biol. 2021;19:e3001425.
    PubMed         Abstract available

    PLoS Genet

  37. BILLMYRE KK, Bravo Nunez MA, Bishop DK, Cole F, et al
    Meiosis in Quarantine discussions lead to an action plan to increase diversity and inclusion within the genetics community.
    PLoS Genet. 2021;17:e1009648.

    PLoS One

  38. FREMPONG NK, Acheampong T, Apenteng OO, Nakua E, et al
    Does the data tell the true story? A modelling assessment of early COVID-19 pandemic suppression and mitigation strategies in Ghana.
    PLoS One. 2021;16:e0258164.
    PubMed         Abstract available

  39. KYNO NM, Fugelseth D, Knudsen LMM, Tandberg BS, et al
    Starting parenting in isolation a qualitative user-initiated study of parents' experiences with hospitalization in Neonatal Intensive Care units during the COVID-19 pandemic.
    PLoS One. 2021;16:e0258358.
    PubMed         Abstract available

  40. BITAR AN, Zawiah M, Al-Ashwal FY, Kubas M, et al
    Misinformation, perceptions towards COVID-19 and willingness to be vaccinated: A population-based survey in Yemen.
    PLoS One. 2021;16:e0248325.
    PubMed         Abstract available

  41. MILLER EM, Law EA, Ajeen R, Karasik J, et al
    SARS-CoV-2 infection in central North Carolina: Protocol for a population-based longitudinal cohort study and preliminary participant results.
    PLoS One. 2021;16:e0259070.
    PubMed         Abstract available

  42. TESEMA AK, Shitu K, Adugna A, Handebo S, et al
    Psychological impact of COVID-19 and contributing factors of students' preventive behavior based on HBM in Gondar, Ethiopia.
    PLoS One. 2021;16:e0258642.
    PubMed         Abstract available

  43. DITOSTO JD, Weiss RE, Yee LM, Badreldin N, et al
    Association of Tdap vaccine guidelines with vaccine uptake during pregnancy.
    PLoS One. 2021;16:e0254863.
    PubMed         Abstract available

  44. SAAD A, Magwood O, Aubry T, Alkhateeb Q, et al
    Mobile interventions targeting common mental disorders among pregnant and postpartum women: An equity-focused systematic review.
    PLoS One. 2021;16:e0259474.
    PubMed         Abstract available

  45. BREJOVA B, Borsova K, Hodorova V, Cabanova V, et al
    Nanopore sequencing of SARS-CoV-2: Comparison of short and long PCR-tiling amplicon protocols.
    PLoS One. 2021;16:e0259277.
    PubMed         Abstract available

    Reasons for nonadherence to vaccination for influenza among older people in Brazil.
    PLoS One. 2021;16:e0259640.
    PubMed         Abstract available

  47. HESSHEIMER AJ, Trapero-Bertran M, Borin A, Butori E, et al
    Resource utilization and outcomes in emergency general surgery during the COVID19 pandemic: An observational cost analysis.
    PLoS One. 2021;16:e0252919.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  48. RABB N, Glick D, Houston A, Bowers J, et al
    No evidence that collective-good appeals best promote COVID-related health behaviors.
    Proc Natl Acad Sci U S A. 2021;118.

  49. PAN K, Chiu Y, Huang E, Chen M, et al
    Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  50. ENDO A, Uchida M, Hayashi N, Liu Y, et al
    Within and between classroom transmission patterns of seasonal influenza among primary school students in Matsumoto city, Japan.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  51. DE HAAS TDJ, Yeung KHT, Hutubessy R, van der Putten IM, et al
    Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
    Vaccine. 2021;39:6762-6780.
    PubMed         Abstract available

  52. CHEN AT, Stacey HD, Marzok A, Singh P, et al
    Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01341.
    PubMed         Abstract available

  53. SANZ-ROJO S, Jimenez-Garcia R, Lopez-de-Andres A, de Miguel-Diez J, et al
    Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020.
    Vaccine. 2021 Nov 3. pii: S0264-410X(21)01392.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.